Immunome Inc
IMNM
$28.01-1.79%
End of day · as of Aug 25, 2026, 8:51 AM ET
Mkt cap
$2.47B
EV/Sales
262.0
P/E ratio
N/A
FY2025 Revenue
$6.94M
EPS (TTM)
$-2.53
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-3059.99%
Beta
2.12
Div yield
N/A
Sector
Healthcare
Immunome Inc (IMNM) is a biotechnology company listed on US.
Latest reported IMNM revenue for 2025-12-31 was $6.9M. Net income was -$212.4M. Revenue was down 23.2% from 2024-12-31 to 2025-12-31. IMNM currently screens at market cap $2.47B.
Use this IMNM research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full IMNM income, balance, and cash tables.
Immunome Inc (IMNM) is a biotechnology company in the Healthcare sector.
Latest cached Immunome Inc (IMNM) revenue for Dec 31, 2025 was $6.9M. Net income was -$212.4M. Statements: https://lician.com/financials/imnm
Immunome Inc (IMNM) market capitalization is $2.47B on the latest cached snapshot.
Immunome Inc (IMNM) cached previous close $28.52; day range $27.64 – $28.85; volume 978,437. Session quote: https://lician.com/quote/imnm
Immunome Inc (IMNM) latest cached earnings event is "IMNM earnings" on Aug 12, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IMNM filing is 8-K · Oct 5, 2026. Filings: https://lician.com/sec/imnm